UPMC Hillman Cancer Center Train the Trainer Chemotherapy Qualification Program, Drug Updates February 22
UPMC Hillman Cancer Center Train the Trainer Chemotherapy Qualification Program: Drug Updates
Monday, February 22, 2021
Shrina Duggal, PharmD, BCOP
UPMC Hillman Cancer Center, Remote Attendance
Disclosure of Conflicts of Interest
All individuals in a position to control the content of this education activity are required to disclose all relevant financial relationships with any proprietary entity producing, marketing, re-selling, or distributing health care goods or services, used on, or consumed by patients.
The following information was provided: The planning committee for this activity did not have any relevant financial relationships with a commercial interest.
The following information was disclosed: Shrina Duggal disclosed salary/royalties from CE Speakers’ Bureau for Incyte, and Astellas/Pfizer; and consulting for UpToDate, Inc.
Oncology nurses throughout Hillman Cancer Center who are Nurse Trainers for their location.
- Identify three new drugs that were added to the drug handling precautions list
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.75 contact hours.
To receive 1.75 Contact Hours, the learner must sign in, attend the entire activity, and complete the activity evaluation.
- 1.75 ANCCUPMC Provider Unit is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation
- 1.75 Attendance